Contact Us
  • 1



    Each ml contains:


    MYDEX ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitis is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.

    The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Staphylococci, including S. aurous and S. epidermidis (coagulase -positive and coagulase-negative), including penicillin-resistant strains. streptococci, including some of the group a beta-hemolytic species, and some Streptococcus pneumonia, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aero genes, Proteus mirabilis. Morganella morganii, most Proteus vulgaris strains, Haemophilus influenza and H. aegyptius, Moraxella lacunata, and Acinetobacter calcoaceticus (Herellea vaginicola) and some Neisseria species.


    Available in 5ml plastic dropper bottle.